NCT07060378View on ClinicalTrials.gov

A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

January 30, 2026

Conditions
Lung LesionsMediastinal and Hilar Lymph Node Enlargement
Interventions
DEVICE

Contrast-enhanced endobronchial ultrasound

Using CE-EBUS to observe pulmonary lesions and abnormal enlarged intrathoracic lymph nodes, the enhancement characteristics of benign and malignant lesions under CE-EBUS were extracted for both conditions.

Trial Locations (1)

Unknown

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER

NCT07060378 - A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes | Biotech Hunter | Biotech Hunter